NCT00061503

Brief Summary

The primary objective of this study is to describe the effect of TRAVATAN 0.004% Ophthalmic Solution on aqueous humor dynamics in subjects with a clinical diagnosis of open angle glaucoma (OAG) or ocular hypertension (OHT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Apr 2003

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2003

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2003

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 30, 2003

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2004

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2004

Completed
Last Updated

August 5, 2008

Status Verified

August 1, 2008

Enrollment Period

11 months

First QC Date

May 28, 2003

Last Update Submit

August 4, 2008

Conditions

GlaucomaOcular Hypertension

Keywords

GlaucomaOcular Hypertension

Interventions

TravoprostDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
* Subjects 18 years of age or older * of either sex * of any race * diagnosed with ocular hypertension or open angle glaucoma

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Alcon Call Center

Call For Details, Nebraska, United States

Location

MeSH Terms

Conditions

GlaucomaOcular Hypertension

Interventions

Travoprost

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

CloprostenolProstaglandins F, SyntheticProstaglandins, SyntheticProstaglandinsEicosanoidsFatty Acids, UnsaturatedFatty AcidsLipidsAutacoidsInflammation MediatorsBiological Factors

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

May 28, 2003

First Posted

May 30, 2003

Study Start

April 1, 2003

Primary Completion

March 1, 2004

Study Completion

March 1, 2004

Last Updated

August 5, 2008

Record last verified: 2008-08

Locations

US(1)